key: cord-0863390-0yn6r66g
authors: Escalon, Joanna G.; Toy, Dennis; Groner, Lauren; Legasto, Alan C.; Weisman, Stacey Versoza; Rotman, Jessica; Asrani, Ashwin V.; Mahmood, Syed S.; Truong, Quynh A.
title: Incidence, clinical associations and outcomes of intrathoracic complications with and without ARDS in COVID-19 pneumonia
date: 2022-03-04
journal: Clin Imaging
DOI: 10.1016/j.clinimag.2022.02.029
sha: 5a4585e1b4746c35f6be55a85cd79242a19e13bc
doc_id: 863390
cord_uid: 0yn6r66g

PURPOSE: To determine the incidence and clinical predictors of intrathoracic complications in COVID-19 patients, and the association with outcomes. METHODS: In this retrospective cross-sectional study, we included 976 patients (age 61 ± 17 years, 62% male) who tested positive for SARS-CoV-2 between March 3–April 4, 2020 and underwent chest imaging. 3836 radiographs from 976 patients and 105 CTs from 88 patients were reviewed for intrathoracic complications, including pneumothorax, pneumomediastinum, pneumopericardium, lobar collapse, pleural effusion, and pneumatocele formation. RESULTS: There was a high rate of intrathoracic complications (197/976, 20%). Pleural effusion was the most common complication (168/976, 17%). Pneumothorax (30/976, 3%) and pneumatoceles (9/88, 10%) were also frequent. History of hypertension and high initial CXR severity score were independent risk factors for complications. Patients with any intrathoracic complication during admission had an over 11-fold risk of ICU admission (adjusted odds ratio [aOR] 11.2, p < 0.0001) and intubation (aOR 12.4, p < 0.0001), over 50% reduction in successful extubation (aOR 0.49, p = 0.02) and longer length of stay (median 13 versus 5 days, p < 0.0001). There was no difference in overall survival between patients with and without any complication (log-rank p = 0.94). CONCLUSION: In COVID-19 patients who underwent chest imaging, 1 in 5 patients have an intrathoracic complication, which are associated with higher level of care and prolonged hospital stay. Hypertension history and high CXR severity score confer an increased risk of complication. SUMMARY: Intrathoracic complications in COVID-19 are common and are predictive of ICU admission, need for intubation, less successful extubation, and longer length of stay but are not predictive of mortality.

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first discovered in December 2019 and resulted in a devasting pandemic, declared by the World Health Organization in March 2020. SARS-CoV-2 causes a respiratory illness termed COVID-19, which ranges from a mild, self-limiting respiratory tract illness to a severe pneumonia that can progress to multiorgan failure and death. 1 Clinical features of SARS-CoV-2 are similar to prior coronavirus-related pulmonary syndromes, specifically those seen in the 2003 outbreak of severe acute respiratory syndrome (SARS-CoV) and the 2012 outbreak of Middle East respiratory syndrome (MERS-CoV). 2 Additionally, SARS-CoV-2 and SARS-CoV appear to share the same human host cell receptor, angiotensinconverting enzyme 2 (ACE2), indicating similar mechanisms of infection. 3 The most common complication of COVID-19 pneumonia is acute respiratory distress syndrome (ARDS). 4 However, there are additional intrathoracic complications may occur in conjunction with or separate from ARDS including pneumothorax, pneumomediastinum, subcutaneous suspected COVID-19 patients that were tested by RT-PCR at [blinded] . The authors have access to the complete medical records and radiology images for [hospital names blinded].

The details of the study population and design were previously reported. 32 In brief, as shown in Figure 1 , we excluded patients with RT-PCR test results that were negative, indeterminate or invalid (n=1563), those whose medical records were unavailable for review (n=1417; 1392 from other [Blinded] Hospitals to which EMR access was inaccessible, 25 restricted healthcare workers), and pediatric cases (n=9). For this analysis, patients were excluded if they did not have at least one CXR or one chest CT (n=145).

A total of 976 patients who tested positive on RT-PCR for COVID-19 and underwent chest imaging were included in the final cohort. All 976 patients had at least one CXR and 88 of those 976 patients also underwent at least one chest CT.

Manual chart review from the electronic medical records was performed for each patient from the time period of April 24, 2020 to May 7, 2020 for the clinical history and outcomes. For the survival analyses, we used the date of the RT-PCR specimen collection of the first positive COVID-19 test to death date or to the last documented note in the electronic medical record when the patient was noted to be alive.

A total of 3836 CXRs from 976 patients were reviewed, of which 3812 were AP portable radiographs (99%) and 24 were PA/lateral radiographs. A total of 105 chest CT scans were performed on 88 patients on at least 32-slice multidetector CT scanners (General Electric Medical Systems, Milwaukee, WI or Siemens, Erlangen, Germany). The CT scans were J o u r n a l P r e -p r o o f Journal Pre-proof performed with (n=67) or without (n=34) intravenous contrast media. All studies were reconstructed with slice thickness ≤ 2.5 mm using soft tissue and lung reconstruction kernels.

The [Blinded] Core Laboratory, which consisted of 6 board-certified radiologists (5 of which were fellowship-trained cardiothoracic radiologists and 1 was a fellowship-trained emergency/musculoskeletal radiologist), interpreted all CXRs. All chest CT scans were interpreted by board-certified cardiothoracic radiologists. All imaging interpretations were performed as group consensus reads between one junior (1-2 years of post-fellowship experience) and one senior radiologist (5, 12, or 14 years of post-fellowship experience), with disagreement resolved by a third senior cardiothoracic radiologist. The readers were aware of the positive RT-PCR but otherwise blinded to the clinical history and outcomes.

Readers reviewed all initial CXRs performed on each patient at presentation and recorded the presence of a complication. Readers then reviewed all additional available CXRs and CTs performed during each patient's emergency department visit or hospitalization related to their positive RT-PCR to determine if complications were present on at least one imaging study. middle, and lower), and each zone was scored with either a 0 (absence of lung abnormality) or 1 (presence of an abnormality which could be interpretated as having COVID-19 involvement).

This scoring system was validated by Toussie et al. 33 CT images were reviewed for the presence or absence of the following findings: (1) pneumothorax, (2) chest tube, (3) pneumomediastinum, (4) pneumopericardium, (5) subcutaneous emphysema, (6) lobar collapse and associated airway findings, (7) pleural effusion and (8) pneumatocele within the lung parenchyma. Presence or absence of pleural thickening or enhancement associated with pleural effusion was also documented. Pneumatoceles were defined as abnormal air-filled spaces in the lungs and characterized as air-filled only or containing an airfluid level. Pneumatoceles were documented to allow assessment of their potential relationship to pneumothorax. Additional lung parenchymal findings were not evaluated as they have been well documented in the literature.

The outcome end points included intensive care unit (ICU) admission, intubation rate, successful extubation rate, hospitalization length of stay (LOS) and all-cause mortality.

Univariate and multivariable logistic regression analyses were employed to determine which clinical predictors were independently associated with having any complications. Clinical predictors for the multivariable analysis were selected based on patient characteristics and presenting vital signs with p<0.1 in Table 1 ), initial CXR severity score, and also included BMI and sex. To determine the association between any complication and the outcomes for ICU stay, intubation, and successful extubation, multivariable logistic regression models were adjusted for potential confounders of baseline clinical non-imaging covariates with a p<0.1 in Table 1 (age, smoking, CAD, HF, presenting DBP,RR, and initial CXR severity score). Comparison of mortality between patients with and without complications were estimated using the product limit (Kaplan-Meier) method and log-rank test. Cox-proportional hazard regression analysis was performed for any initial CXR complications, and adjusted for age, sex, RR, BMI, DBP, initial CXR severity score, and history of smoking, hypertension, CAD, and HF. A 2-tailed p-value <0.05 was considered statistically significant. SAS version 9.4 (SAS Institute Inc., Cary, NC) was used to perform all statistical analyses.

There were 976 patients testing positive for SARS-CoV-2 who underwent chest imaging.

Demographics and clinical characteristics are detailed in Table 1 .

Patients with complications were older than patients without complications (p-value <0.0001).

Patients with complications were more likely to have a history of smoking, hypertension, CAD or heart failure (all p≤0.01) and presented with a higher respiratory rate (p=0.0001). Patients with complications were more likely to have a CXR severity score of 4 or higher (p≤0.0004). In multivariable analysis, history of heart failure or hypertension, elevated presenting respiratory rate, and CXR severity score of 5 or 6 remained independent risk factors for complication (p ≤0.01, Table 2 ). Given that pleural effusions may be secondary to heart failure, repeat multivariable analysis was performed excluding pleural effusions. 76 (76/976, 8%) patients had a non-pleural effusion complication. Only hypertension and CXR severity score of 5 or 6 remained independent risk factors for complication (both p≤0.04, Table 2 ). There was a 2-fold increase risk for a complication (not including pleural effusion) if the patient had a history of hypertension (adjusted OR 2.09, 95% CI 1.15-3.75, p=0.01). Table 1 summarizes the number of chest imaging studies performed and CXR severity scores for all patients as well as stratified by those with and without complications. All 976 patients underwent at least one CXR (AP CXR, PA/lateral, or both) with a total number of performed J o u r n a l P r e -p r o o f studies as follows: total CXRs (n=3836), AP portable CXRs (n=3812), PA/lateral CXRs (n=24). 88 patients also underwent chest CT (n=108). Nearly all patients received at least one AP CXR (99%). There was no difference in the proportion of patients who underwent CXRs, either portable or PA/lateral, between patients with complications and those without (both p≥0.37).

Patients with complications were more likely to undergo chest CT of any type (p-value <0.0001).

Intrathoracic complication rates are detailed in Table 3 and two illustrative cases are presented in CTs (n = 88). Subgroup rates are also presented for initial CXR alone, any CXR during admission, and any chest CT during admission.

197 patients (197/976, 20%) had at least one complication on either CXR or CT. Pleural effusion was the most common complication (168/976, 17%) followed by pneumothorax (30/976, 3%) and lobar collapse (27/976, 3%). Chest tube placement, subcutaneous emphysema, pneumomediastinum and pneumopericardium were rare. On initial CXR alone, pleural effusion was the most common complication (51/976, 5%). Other complications were rare including spontaneous pneumothorax (3/976, 0.3%) and pneumomediastinum (2/976, 0.2%).

In patients who underwent CT, pleural effusion was again the most common complication, present in more than one-third of patients (31/88, 35%) and complex by imaging in a minority of patients (<10%). Pneumotocele formation was the second most common complication (9/88, J o u r n a l P r e -p r o o f 10%) with two-thirds being air-only and one-third demonstrating an air-fluid level.

Pneumothorax was the third most common complication (7/88, 8%). Pneumothoraces were bilateral in approximately one-third of patients (2/7, 29%) and loculated in nearly half of patients (3/7, 43%). Of the 9 patients who had a pneumothorax on either radiograph or CT and underwent CT during their admission, 2 (2/9, 22%) had either a pneumatocele with air-fluid level or an airfilled pneumatocele. Chest tube placement was required in only 6% (5/88) of patients.

Pneumomediastinum, subcutaneous emphysema and lobar collapse were rare findings.

A total of 277 patients (277/976, 28%) were admitted to the ICU. 252 (252/976, 26%) patients were intubated and 78 (78/252, 31%) had been successfully extubated by the time of study termination.

The differences in the proportion of patients with and without ICU admission, intubation, and successful extubation by complication types are detailed in Supplemental Table 1 (based on any

In this study we observed an intrathoracic complications rate of 20% in a large cohort of patients with COVID-19 who underwent chest imaging. We provide a detailed assessment of the rates of intrathoracic complications in COVID-19 and their association with co-morbidities, presenting symptoms and outcomes. This adds to our understanding of the pathophysiology of COVID-19 and has several implications for patient care.

Many of the complications we evaluated (namely, pneumothorax, pneumomediastinum, pneumopericardium, subcutaneous emphysema) can occur due to barotrauma or spontaneously. In prior coronavirus-related pulmonary syndromes (SARS-CoV and MERS-CoV), mechanically ventilated patients demonstrated high rates of barotrauma (12-34%). [7] [8] [9] McGuinness et al. observed a similar high incidence of barotrauma in patients with COVID-19 related acute respiratory syndrome (ARDS) (24%), greater than non-COVID-19 related ARDS. 28 Our study had similarly high rates of complications in intubated patients (19% with pneumothorax and 10% with pneumomediastinum) compared to never intubated patients (6.5% and 5%, respectively) and at presentation (0.3% and 0.2%, respectively), supporting the notion that coronavirus uniquely increases barotrauma risk. It is known that patients with ARDS are more likely to develop pneumatoceles and pneumothorax related to barotrauma 31 , but the high rates of barotrauma in COVID-19 compared to typical pneumonia induced ARDS raises concern for a distinct lung pathophysiology underlying COVID-19. 28, 34 The exact mechanism of spontaneous pneumothorax and pneumomediastinum in COVID-19 is likely multi-factorial J o u r n a l P r e -p r o o f centering around alveolar damage and rupture related to infection and increased intrathoracic pressure from coughing leading to interstitial emphysema and pneumatocele formation. 29, 35 Of note, our rates of pneumothorax (0.3%) and pleural effusion (5%) based on initial CXR in COVID-19 were similar to those previously reported (pneumothorax rates of 1-2% 14,15,21 and effusion rates of 1-10%. 22, 24, 26, 27 ). Our rates of pneumothorax (3%) and pleural effusion (17%) on any chest imaging during admission were higher than previously reported. This difference is likely related to our larger sample size, inclusion of portable CXRs, and inclusion of a breadth of illness severity ranging from those discharged from the ED to those requiring protracted ICU stays. Additionally, pleural effusion rate could be overestimated on CXR if extensive basilar consolidation was present. Moreover, some studies have reported as association between pneumothorax, subcutaneous emphysema, and pneumomediastinum and worse prognosis. This discrepancy is likely related to a focus on only hospitalized/ICU patients or small sample size. 5, 36 The ability to predict who may need a higher level of care may aid in clinical decision-making such as degree of patient monitoring (i.e. remote home monitoring versus admission). We observed that history of hypertension and higher respiratory rate on presentation were independent risk factors for developing an intrathoracic complication. Presence of any intrathoracic complication was a predictor for ICU admission, intubation, failure to extubate and longer LOS without difference in overall survival. This is in keeping with a recent study of mechanically ventilated patients with COVID-19 showing no difference in the survival for patients with and without barotrauma. 28 J o u r n a l P r e -p r o o f Furthermore, prognostic information gleaned from imaging can inform conversations between physicians, patients and their families, potentially alleviating patient and family anxiety and facilitating goals of care discussions. For example, pneumothorax, chest tube placement, pneumomediastinum, and pleural effusions were predictors of failure to extubate while other complications such as pneumomediastinum and lobar collapse were not. It may provide comfort that certain otherwise disconcerting findings do not necessarily correlate with mortality, although they may predict significant morbidity (e.g. tracheostomy).

Many institutions have successfully instituted a multidisciplinary approach to the care of patients with COVID-19; however, the radiologist has been notably absent from the table. 37,38 The association between imaging findings and outcomes highlights the vital role of the radiologist and supports the need for radiologists to be actively involved with interdisciplinary care teams to provide imaging interpretation and insight into the implication of complications.

This study has important limitations. Our cohort was derived from two large tertiary academic hospitals and ambulatory outpatient practices in Manhattan at the earliest stages of the pandemic and may therefore not be generalizable to dissimilar hospitals or practices, such as community or rural hospitals and practices, or those that are underfunded or under-resourced. Patients hospitalized with COVID-19 today may face a lower incidence of thoracic complications and outcomes may be improved given advances in therapy and management. Our cohort is composed of symptomatic RT-PCR (+) patients identified during the first month of the pandemic when the testing availability was limited. We hope our inclusion of a broad range of illness severities makes our findings more widely applicable and adds to the literature a more J o u r n a l P r e -p r o o f comprehensive assessment not solely focusing on severe presentations. Timing of complications relative to each other or to other events was not recorded. Specifically, timing of complications relative to intubation or chest tube placement (before or after) was not determined and; therefore, it was not determined whether these complications were secondary to barotrauma, chest tube placement or spontaneous. Additionally, the timing or purpose (drainage of effusion or treatment of pneumothorax) of chest tube placement was not known. Our aim was to determine the overall rate rather than the specific etiologies of these complications as mechanically ventilated patients have been independently studied. Finally, severity of pneumonia was not documented as it is now well known to be associated with poor prognosis in COVID-19 yet this may be a confounding factor. Table 1 (age, smoking, hypertension, coronary artery disease, heart failure, presenting diastolic blood pressure and respiratory rate). J o u r n a l P r e -p r o o f 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome

COVID-19, SARS and MERS: are they closely related?

Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey

Is Spontaneous Pneumomediastinum a Poor Prognostic Factor in Covid-19?

Clinical characteristics of COVID-19 complicated with pleural effusion

Pneumothorax and mortality in the mechanically ventilated SARS patients: a prospective clinical study. Crit Care

Critically ill patients with severe acute respiratory syndrome

Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Severe acute respiratory syndrome complicated by spontaneous pneumothorax. Chest

High-resolution CT findings in patients with severe acute respiratory syndrome: a pattern-based approach

Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

COVID-19 with cystic features on computed tomography: A case report

Management of Persistent Pneumothorax With Thoracoscopy and Bleb Resection in COVID-19 Patients

COVID-19 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema

Spontaneous Pneumomediastinum: A Probable Unusual Complication of Coronavirus Disease 2019 (COVID-19) Pneumonia

Analysis of 92 deceased patients with COVID

Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection

CT Features of Coronavirus Disease

Radiological findings from 81 patients with COVID-19

China: a descriptive study

COVID-19): A Systematic Review of Imaging Findings in 919 Patients

CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity

Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation

Pneumomediastinum and spontaneous pneumothorax as an extrapulmonary complication of COVID-19

Spontaneous pneumomediastinum in a male adult with COVID-19 pneumonia

The acute respiratory distress syndrome

Imaging Utilization and Outcomes in Vulnerable Populations during COVID-19 in New York City. Radiol Cardiothorac Imaging

Clinical and Chest Radiography Features Determine Patient Outcomes In Young and Middle Age Adults with COVID-19

Clinical Characteristics and Outcome of Pneumomediastinum in Patients with COVID-19 Pneumonia

Bilateral spontaneous pneumothorax in SARS-CoV-2 infection: A very rare, life-threatening complication